These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22695621)

  • 1. Alzheimer's disease-related lesions.
    Alafuzoff I
    J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 3. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular pathology of Alzheimer's disease.
    Harrington CR
    Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.
    Goudsmit J
    Eur J Epidemiol; 2016 Feb; 31(2):99-105. PubMed ID: 27017509
    [No Abstract]   [Full Text] [Related]  

  • 8. Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging.
    Bouras C; Kovari E; Savioz A; Giacobini E; Xekardaki A
    Adv Exp Med Biol; 2015; 822():17. PubMed ID: 25416972
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
    Aho L; Parkkinen L; Pirttila T; Alafuzoff I
    Dement Geriatr Cogn Disord; 2008; 25(5):423-32. PubMed ID: 18391488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease.
    Wang J; Ho L; Qin W; Rocher AB; Seror I; Humala N; Maniar K; Dolios G; Wang R; Hof PR; Pasinetti GM
    FASEB J; 2005 Apr; 19(6):659-61. PubMed ID: 15650008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: β-amyloid plaque formation in human brain.
    Seeman P; Seeman N
    Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?
    Weller RO; Hawkes CA; Carare RO; Hardy J
    Acta Neuropathol; 2015 May; 129(5):763-6. PubMed ID: 25814152
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
    Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
    J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
    Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H
    Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
    Rabinovici GD; Roberson ED
    Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicine. Prion-like behavior of amyloid-beta.
    Kim J; Holtzman DM
    Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.